BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 5004351)

  • 21. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyrazinamide resistance in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Abkhazia.
    Pardini M; Varaine F; Hewison C; Iona E; Pataracchia M; Orefici G; Fattorini L
    J Chemother; 2007 Feb; 19(1):106-7. PubMed ID: 17309862
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro antimycobacterial activities of pyrazinamide analogs: results of screening tests].
    Yamamoto S; Toida I; Watanabe N; Ura T
    Kekkaku; 1996 Mar; 71(3):253-8. PubMed ID: 8901227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial and acquired drug resistance of Mycobacterium tuberculosis in east Delhi.
    Mahajan M; Agarwal DS; Gadre DJ; Singh NP; Gupta HC; Talwar V
    J Commun Dis; 1996 Mar; 28(1):15-9. PubMed ID: 8778175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of sensitivity and specificity in anti-tubercular drug sensitivity tests].
    no author
    Kekkaku; 2008 Dec; 83(12):799-801. PubMed ID: 19192510
    [No Abstract]   [Full Text] [Related]  

  • 28. [The effects of antituberculous chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli (author's transl)].
    Uratsuji Y
    Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):20-9. PubMed ID: 99201
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vivo and in vitro experimental research on polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Termine A
    Ann Ist Carlo Forlanini; 1969; 29(4):301-16. PubMed ID: 5004329
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyrazinamide susceptibility testing in all isolates of the Mycobacterium tuberculosis complex - a critical analysis.
    Cunha J
    Rev Port Pneumol; 2012; 18(4):188-9. PubMed ID: 22257727
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 32. [Studies on the assay method of microbiologically active concentrations in the sensitivity test media for antituberculous agents. 2].
    Kanazawa Y; Kuramata T
    Kekkaku; 1970 Dec; 45(12):423-8. PubMed ID: 4992793
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of the sensitivity of tuberculosis bacteria to pyrazinamide using human macrophage culture].
    Salfinger M; Crowle AJ
    Pneumologie; 1990 Feb; 44 Suppl 1():460-1. PubMed ID: 2114631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The curious characteristics of pyrazinamide: a review.
    Zhang Y; Mitchison D
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):6-21. PubMed ID: 12701830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogs of the antituberculous agent pyrazinamide are competitive inhibitors of NADPH binding to M. tuberculosis fatty acid synthase I.
    Sayahi H; Pugliese KM; Zimhony O; Jacobs WR; Shekhtman A; Welch JT
    Chem Biodivers; 2012 Nov; 9(11):2582-96. PubMed ID: 23161636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Action of protionamide on tuberculosis mycobacteria in vitro].
    Kalabukha AV; Klimenko MT
    Mikrobiol Zh; 1972; 34(6):778-82. PubMed ID: 4199956
    [No Abstract]   [Full Text] [Related]  

  • 37. [Development of resistance to Mycobacterium tuberculosis in Chile].
    Valenzuela P; Lepe R; Ponce De León L; Ponce J; Saldias P; Silva S
    Rev Med Chil; 1973 Jan; 101(1):30-3. PubMed ID: 4201841
    [No Abstract]   [Full Text] [Related]  

  • 38. [Action in vitro of associations of tuberculostatic drugs on strains of mycobacteria with multiple drug resistance].
    Timośca S; Coman G; Petreanu V; Georgescu M; Balteanu E
    Rev Med Chir Soc Med Nat Iasi; 1975; 79(1):49-53. PubMed ID: 806949
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensitivity of tubercle bacilli to pyrazinamide determined on the basis of their sensitivity to nicotinamide and their pyrazinamidase and nictinamidase activities].
    Tatar J
    Gruzlica; 1974 Aug; 42(8):773-7. PubMed ID: 4277272
    [No Abstract]   [Full Text] [Related]  

  • 40. Microbiology and diagnosis of tuberculosis.
    Fadda G; Sanguinetti M
    Rays; 1998; 23(1):32-41. PubMed ID: 9673132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.